• Department of Medicine
  • kj_med@ummc.edu.my
  • 03-7949 2429
logo
logo

2024 Publications

No. Publications

1

Ooi YG, Sarvanandan T, Hee NK, Lim QH, Paramasivam SS, Ratnasingam J, Vethakkan SR, Lim SK, Lim LL. Risk Prediction and Management of Chronic Kidney Disease in People Living with Type 2 Diabetes Mellitus. Diabetes Metab J. 2024 Mar;48(2):196-207.

2

Lim LL, Hussein Z, Noor NM, Raof ASA, Mustafa N, Bidin MBL, et al. Real-world evaluation of care for type 2 diabetes in Malaysia: A cross-sectional analysis of the treatment adherence to guideline evaluation in type 2 diabetes (TARGET-T2D) study. PLoS ONE 2024; 19(1): e0296298.

3

Ratnasingam J, Niyaz M, Mariyappan S, Ong T, Chan SP, Hew FL, Yeap SS, Velaiutham S, Thambiah SC, Lekamwasam S. Age-dependent FRAX-based assessment and intervention thresholds for therapeutic decision making in osteoporosis in the Malaysian population. Archives of Osteoporosis. 2024 Mar 20;19(1):18.

2023 Publications

No. Publications

1

Ahmad, A., Lim, L. L., Morieri, M. L., Tam, C. H. T., Cheng, F., Chikowore, T., ... & Mathioudakis, N. N. (2023). Precision Prognostics for Cardiovascular Disease in Type 2 Diabetes: A Systematic Review and Meta-analysis. medRxiv, 2023-04.

2

Bidin, M. B. L., Khan, A. M., Tan, F. H. S., Aziz, N. A., Ali, N. M., Kamaruddin, N. A., ... & Hussein, Z. (2023). Patient Characteristics, Disease Burden, Treatment Patterns and Outcomes in Patients with Acromegaly: Real-World Evidence from the Malaysian Acromegaly Registry. Journal of the ASEAN Federation of Endocrine Societies.

3

Borhan, M. K., Vethakkan, S. R., Sarvanandan, T., & Paramasivam, S. S. (2023). A Case of Severe Lactation Ketoacidosis in a Nondiabetic Mother on a Ketogenic Diet. JCEM Case Reports, 1(6), luad134.

4

Chan, S. P., Lim, L. L., Chan, J. C., & Matthews, D. R. (2023). Adjusting the Use of Glucose-Lowering Agents in the Real-World Clinical Management of People with Type 2 Diabetes: A Narrative Review. Diabetes Therapy, 1-16.

5

Chan, S. P., Mumtaz, M., Ratnasingam, J., Tan, A. T. B., Lim, S. C., Rosman, A., ... & Mohamed, M. (2023). Practical guide in using insulin degludec/insulin aspart: A multidisciplinary approach in Malaysia. Malaysian family physician: the official journal of the Academy of Family Physicians of Malaysia, 18, 31.

6

Chan, W. K., Chuah, K. H., Rajaram, R. B., Lim, L. L., Ratnasingam, J., & Vethakkan, S. R. (2023). Metabolic dysfunction-associated Steatotic Liver disease (MASLD): a state-of-the-art review. Journal of Obesity & Metabolic Syndrome, 32(3), 197.

7

Cheah, M. H., Lai, P. S. M., Khor, H. M., Ratnasingam, J., Chandrasekaran, C. S. K., Singh, S., ... & Ong, T. (2023). Fragility fracture care gap at a tertiary teaching hospital in Malaysia. Archives of Osteoporosis, 18(1), 63.

8

Dou, Q., Chakrabarty, S., Wu, D., Tam, L. S., Jin, Y. Z., So, H., ... & Zou, L. (2023). The temporal trend of disease burden attributable to metabolic risk factors in China,–: An analysis of the Global Burden of Disease study. Nutrition and Metabolic Aging.

9

Fung, E., Ng, K. H., Kwok, T., Lui, L. T., Palaniswamy, S., Chan, Q., ... & Woo, J. (2023). Divergent Survival Outcomes Associated with Elevated Branched-Chain Amino Acid Levels among Older Adults with or without Hypertension and Diabetes: A Validated, Prospective, Longitudinal Follow-Up Study. Biomolecules, 13(8), 1252.

10

Gregg, E. W., Buckley, J., Ali, M. K., Davies, J., Flood, D., Mehta, R., ... & Zhumadilov, Z. (2023). Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact. The Lancet, 401(10384), 1302-1312.

11

Hee, N. K. Y., Lim, Q. H., Paramasivam, S., Lim, L. L., Vethakkan, S., Ganapathy, S. S., & Ratnasingam, J. (2023). The use of prednisolone during Ramadan fasting in patients with adrenal insufficiency. Clinical endocrinology.

12

Hoo, J. X., Yang, Y. F., Tan, J. Y., Yang, J., Yang, A., & Lim, L. L. (2023). Impact of multicomponent integrated care on mortality and hospitalization after acute coronary syndrome: a systematic review and meta-analysis. European Heart Journal-Quality of Care and Clinical Outcomes, 9(3), 258-267.

13

Jin, Y., So, H., Cerin, E., Barnett, A., Mubarik, S., Hezam, K., ... & Wu, D. (2023). The temporal trend of disease burden attributable to metabolic risk factors in China, 1990–2019: An analysis of the Global Burden of Disease study. Frontiers in Nutrition, 9, 1035439.

14

Lazarus, J. V., Han, H., Mark, H. E., Alqahtani, S. A., Schattenberg, J. M., Soriano, J. B., ... & Perna, S. (2023). The global Fatty Liver Disease-Sustainable Development Goal country score for 195 countries and territories. Hepatology, 10-1097.

15

Lee, J. J. N., Abdul Aziz, A., Chan, S. T., Raja Abdul Sahrizan, R. S. F. B., Ooi, A. Y. Y., Teh, Y. T., ... & Lim, L. L. (2023). Effects of mobile health interventions on health‐related outcomes in older adults with type 2 diabetes: A systematic review and meta‐analysis. Journal of diabetes, 15(1), 47-57.

16

Liew, A., Lydia, A., Matawaran, B. J., Susantitaphong, P., Tran, H. T. B., & Lim, L. L. (2023). Practical considerations for the use of SGLT‐2 inhibitors in the A sia–P acific countries—An expert consensus statement. Nephrology.

17

Lim, L. L., Aziz, A. A., Dakin, H., Buckell, J., Woon, Y. L., Roope, L., ... & Clarke, P. M. (2023). Trends in all-cause mortality among adults with diagnosed type 2 diabetes in West Malaysia: 2010–2019. Diabetes Research and Clinical Practice, 205, 110944.

18

Lim, L. L., Chow, E., & Chan, J. C. (2023). Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice. Nature Reviews Endocrinology, 19(3), 151-163.

19

Lim, L. L., Lau, E. S., Chan, S. P., Ji, L., Lim, S., Sirinvaravong, S., ... & Chan, J. C. (2023). Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) Register. Diabetes Research and Clinical Practice, 110855.

20

Lim, L. L., Lau, E. S., Cheung, J. T., Chan, S. P., Ji, L., Lim, S., ... & Chan, J. C. (2023). Real‐world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register. Diabetes, Obesity and Metabolism, 25(1), 208-221.

21

Lim, L. L., Lau, E. S., Kong, A. P., Fu, A. W., Lau, V., Jia, W., ... & Chan, J. C. (2023). Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program. The Lancet Regional Health–Western Pacific, 32.

22

Lim, Q. H., Lau, E. S., & Lim, L. L. (2023). The need for population-specific cardiovascular risk prediction models for guiding risk stratification and treatment approaches in type 2 diabetes. European Journal of Preventive Cardiology, 30(12), 1291-1292.

23

Loh, H. H., Lim, Q. H., Chai, C. S., Goh, S. L., Lim, L. L., Yee, A., & Sukor, N. (2023). Influence and implications of the renin–angiotensin–aldosterone system in obstructive sleep apnea: An updated systematic review and meta‐analysis. Journal of sleep research, 32(1), e13726.

24

Loh, H. H., Lim, Q. H., Kang, W. H., Yee, A., Yong, M. C., & Sukor, N. (2023). Obstructive sleep apnea and vitamin D: an updated systematic review and meta-analysis. Hormones, 22(4), 563-580.

25

Micah, A. E., Bhangdia, K., Cogswell, I. E., Lasher, D., Lidral-Porter, B., Maddison, E. R., ... & Hlongwa, M. M. (2023). Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026. The Lancet Global Health, 11(3), e385-e413.

26

Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., ... & Brauer, M. (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet..

27

Ong, T. I. W., Lim, L. L., Chan, S. P., Chee, W. S. S., Ch’ng, A. S. H., Chong, E. G. M., ... & Yeap, S. S. (2023). A summary of the Malaysian Clinical Practice Guidelines on the management of postmenopausal osteoporosis, 2022. Osteoporosis and Sarcopenia.

28

Parra-Mujica, F., Roope, L. S., Abdul-Aziz, A., Mustapha, F., Ng, C. W., Rampal, S., ... & Clarke, P. (2023). Health poverty among people with type 2 diabetes mellitus (T2DM) in Malaysia. Social Science & Medicine, 116426.

29

Perumalsamy, S., Huri, H. Z., Abdullah, B. M., Mazlan, O., Wan Ahmad, W. A., & Vethakkan, S. R. D. (2023). Genetic markers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease. Metabolites, 13(3), 427.

30

Tobias, D. K., Merino, J., Ahmad, A., Aiken, C., Benham, J. L., Bodhini, D., ... & Nolan, J. J. (2023). Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nature Medicine, 1-20.

31

Yang, Y. F., Hoo, J. X., Tan, J. Y., & Lim, L. L. (2023). Multicomponent integrated care for patients with chronic heart failure: systematic review and meta‐analysis. ESC heart failure, 10(2), 791-807.

32

Zhang, X., Yip, T. C. F., Wong, G. L. H., Leow, W. X., Liang, L. Y., Lim, L. L., ... & Wong, V. W. S. (2023). Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial. Gut, 72(12), 2364-2371.

2022 Publications

No. Publications

1

Bernard, D. M. A., Wen, L. S., Yoong, N. H. K., Hziung, L. Q., Lachumanan, D., Paramasivam, S. S., ... & Vethakkan, S. R. D. (2022). ACROMEGALY WITH SPONTANEOUS VENTRICULOSTOMY-A RARE PHENOMENON. Journal of the ASEAN Federation of Endocrine Societies, 37(S2), 44-45.

2

Bryazka, D., Reitsma, M. B., Griswold, M. G., Abate, K. H., Abbafati, C., Abbasi-Kangevari, M., ... & Diress, M. (2022). Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. The Lancet, 400(10347), 185-235.

3

Burkart, K., Causey, K., Cohen, A. J., Wozniak, S. S., Salvi, D. D., Abbafati, C., ... & Nangia, V. (2022). Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2· 5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019. The Lancet Planetary Health, 6(7), e586-e600.

4

Chan, J. C., Thewjitcharoen, Y., Nguyen, T. K., Tan, A., Chia, Y. C., Hwu, C. M., ... & Luk, A. O. (2022). Effect of a Web-Based Management Guide on Risk Factors in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A JADE Randomized Clinical Trial. JAMA network open, 5(3), e223862-e223862.

5

Cheung, J. T., Lau, E., Tsui, C. C., Siu, E. L., Tse, N. K., Hui, N. Y., ... & Chan, J. C. (2022). Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries. BMC medicine, 20(1), 1-16.

6

Cousin, E., Duncan, B. B., Stein, C., Ong, K. L., Vos, T., Abbafati, C., ... & Haque, S. (2022). Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. The Lancet diabetes & endocrinology, 10(3), 177-192. Ting, C. Y., Tan, S. Y., Gan, G. G., Zain, S. M., Pung, Y. F., Ong, D. B. L., & Bee, P. C. (2022).

7

Haakenstad, A., Irvine, C. M. S., Knight, M., Bintz, C., Aravkin, A. Y., Zheng, P., ... & Sahu, M. (2022). Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet.

8

Hee, N. K. Y., Lim, Q. H., Lim, L. L., Paramasivam, S., Vethakkan, S., Chan, S. P., & Ratnasingam, J. (2022). ODP173 Control of Alpelisib-Induced Hyperglycemia With DPP4-Inhibitors as add on to Metformin and Insulin. Journal of the Endocrine Society, 6(Supplement_1), A303-A303.

9

Hoo, J. X., Yang, Y. F., Tan, J. Y., Yang, J., Yang, A., & Lim, L. L. Impact of multicomponent integrated care on mortality and hospitalization after acute coronary syndrome: a systematic review and meta-analysis. European Heart Journal-Quality of Care and Clinical Outcomes.

10

Kahar, N., Hziung, L. Q., Ibrahim, L., Ratnasingam, J., Vethakkan, S., Lim, L. L., & Paramasivam, S. (2022). DESCRIPTIVE COST ANALYSIS OF TELECONSULTATION IN UMMC DIABETES CLINIC. Journal of the ASEAN Federation of Endocrine Societies, 37(S2), 55-55.

11

Kalra, S., Dhar, M., Afsana, F., Aggarwal, P., Aye, T. T., Bantwal, G., ... & Jawdekar, A. (2022). Asian Best Practices for Care of Diabetes in Elderly (ABCDE). Review of Diabetic Studies, 18(2), 100-134.

12

Kang, W. H., Mohamad Sithik, M. N., Khoo, J. K., Ooi, Y. G., Lim, Q. H., & Lim, L. L. (2022). Gaps in the management of diabetes in Asia: A need for improved awareness and strategies in men's sexual health. Journal of Diabetes Investigation.

13

Leal, J., Becker, F., Lim, L. L., Holman, R. R., & Gray, A. M. (2022). Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double‐blind, placebo‐controlled trial. Journal of diabetes, 14(7), 455-464.

14

Lim, L. L., Chow, E., & Chan, J. C. (2022). Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice. Nature Reviews Endocrinology, 1-13.

15

Lim, L. L., Lau, E. S., Cheung, J. T., Chan, S. P., Ji, L., Lim, S., ... & Chan, J. C. (2022). Real world usage of sulphonylurea in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) Register. Diabetes, Obesity and Metabolism.

16

Lim, L. L., Lau, E. S., Kong, A. P., Fu, A. W., Lau, V., Jia, W., ... & Chan, J. C. (2022). Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: A cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program. The Lancet Regional Health-Western Pacific, 100663.

17

Lim, L. L., Lau, E. S., Ozaki, R., So, T. T., Wong, R. Y., Chow, E. Y., ... & Kong, A. P. (2022). Team-based multicomponent care improved and sustained glycaemic control in obese people with type 2 diabetes (T2D) in a Diabetes Centre setting: a quality improvement program with quasi-experimental design. Diabetes Research and Clinical Practice, 110138.

18

Loganadan NK, Huri HZ, Vethakkan SR, Hussein Z. IDF21-0069 Beta-cell function and insulin resistance of type 2 diabetes patients on maximum doses of sulphonylurea-metformin. Diabetes Research and Clinical Practice. 2022 Apr 1;186.

19

Loh, H. H., Lim, Q. H., Chai, C. S., Goh, S. L., Lim, L. L., Yee, A., & Sukor, N. (2022). Influence and implications of the renin–angiotensin–aldosterone system in obstructive sleep apnea: An updated systematic review and meta‐analysis. Journal of Sleep Research, e13726.

20

Ng YM, Ratnasingam J, Lim LL, Paramasivam SS, Ibrahim L, Lim QH, Chiong TP, Omar SZ, Vethakkan SR. IDF21-0025 Impact of different GDM diagnostic criteria on GDM incidence, therapy and postpartum dysglycemia in Malaysian women. Diabetes Research and Clinical Practice. 2022 Apr 1;186.

21

Ooi, X. Y., Aziz, N. I., Lim, L. L., Paramasivam, S., Vethakkan, S., Chan, S. P., ... & Ratnasingam, J. (2022). ODP346 Prevalence and Predictors of Endocrinopathies Amongst Patients on Chronic Opioid Use for Non-Cancer Pain. Journal of the Endocrine Society, 6(Suppl 2), A507.

22

Sethi B, Al-Rubeaan K, Unubol M, Mabunay MA, Berthou B, Pilorget V, Vethakkan SR, Frechtel G. Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study. Diabetes Therapy. 2022 Jul;13(7):1395-408.

23

Sthaneshwar, P., Zainuddin, N. M., & Ratnasingam, J. (2022). Improvement in polycythaemia vera after parathyroidectomy for primary hyperparathyroidism. Singapore Med J, 1, 6.

24

Tai, Y. T., Lim, Q. H., Ratnasingam, J., Paramasivam, S. S., Tan, P. C., Omar, S. Z., ... & Vethakkan, S. R. (2022). ODP413 Impact of Gestational Weight Gain according to 2009 IOM Recommendations on Neonatal Anthropometrics in Asians: A Pilot Study from Malaysia. Journal of the Endocrine Society, 6(Suppl 1), A662.

25

Tan, H. T., Tan, C. Y., Teong, C. S., Ratnasingam, J., & Goh, K. J. (2022). Prolonged Exercise Test in Patients With History of Thyrotoxicosis. Journal of Clinical Neurophysiology, 39(4), 307-311.

26

Tee, K. B., Ibrahim, L., Hashim, N. M., Saiman, M. Z., Zakaria, Z. H., & Huri, H. Z. (2022). Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes. Pharmaceutics, 14(6), 1268.

27

Tee, K. B., Ibrahim, L., Hashim, N. M., Saiman, M. Z., Zakaria, Z. H., & Huri, H. Z. (2022). Pharmacokinetics and Metabolomic Profiling of Metformin and Andrographis paniculata: A Protocol for a Crossover Randomised Controlled Trial. Journal of Clinical Medicine, 11(14), 3931.

28

Teh, H. S., Woon, Y. L., Leong, C. T., Hing, N. Y. L., Mien, T. Y. S., Roope, L. S., ... & Buckell, J. (2022). Malaysian public preferences and decision making for COVID-19 vaccination: A discrete choice experiment. The Lancet Regional Health-Western Pacific, 27, 100534.

29

Wong, A. H., Wong, W. K., Looi, L. M., Ratnasingam, J., & Lim, S. K. (2022). Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement. Case Reports in Nephrology and Dialysis, 12, 105-111.

30

Yang, Y. F., Hoo, J. X., & Lim, L. L. (2022). IDF21-0244 Multicomponent integrated care and clinical outcomes in people with heart failure: A systematic review and meta-analysis. Diabetes Research and Clinical Practice, 186.

31

Yang, Y. F., Hoo, J. X., Tan, J. Y., & Lim, L. L. (2022). Multicomponent integrated care for patients with chronic heart failure: systematic review and meta‐analysis. ESC Heart Failure.
No. Publications

1

Tan, E. Z., Lai, L. L., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., & Chan, W. K. (2021). Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus. Journal of gastroenterology and hepatology, 36(3), 751–757. https://doi.org/10.1111/jgh.15160

2

Loganadan, N. K., Huri, H. Z., Vethakkan, S. R., & Hussein, Z. (2021). Pharmacogenetics of sulfonylurea-induced hypoglycemia in Type 2 diabetes patients: the SUCLINGEN study. Pharmacogenomics, 22(16), 1057-1068.

3

Oo, M. M., Zhen, I. T. C., Ng, K. S., Tan, K. L., Tan, A. T., Vethakkan, S. R., & Chee, K. H. (2021). Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease. BMJ open, 11(1), e039869.

4

Sandhu, A. K., Toh, L. S., Lee, Y. K., Tan, A. T. B., Ratnasingam, J., Thiagarajan, N., & Lai, P. S. M. (2021). Cross-cultural adaptation and validation of the Malay satisfaction questionnaire for osteoporosis prevention in Malaysia. Patient preference and adherence, 15, 1383.

5

Loh, H. H., Francis, B., Lim, L. L., Lim, Q. H., Yee, A., & Loh, H. S. (2021). Improvement in mood symptoms​ after post‐bariatric surgery among people with obesity: A systematic review and meta‐analysis. Diabetes/Metabolism Research and Reviews, 37(8), e3458.

6

Ward, J. L., Azzopardi, P. S., Francis, K. L., Santelli, J. S., Skirbekk, V., Sawyer, S. M., ... & Constantin, T. V. (2021). Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 398(10311), 1593-1618.

7

Paulson, K. R., Kamath, A. M., Alam, T., Bienhoff, K., Abady, G. G., Abbas, J., ... & Chanie, W. F. (2021). Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. The Lancet, 398(10303), 870-905.

8

Chan, J. C., Lim, L. L., Shaw, J. E., Aguilar-Salinas, C. A., & Gregg, E. W. (2021). Data on diabetes-specific distress are needed to improve the quality of diabetes care–Authors' reply. The Lancet, 397(10290), 2150

9

Lim, L. L., Lau, E. S., Fu, A. W., Ray, S., Hung, Y. J., Tan, A. T., ... & Asia-Pacific JADE Study Group. (2021). Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial. JAMA network open, 4(4), e217557-e217557.

10

Lim, Q. H., & Lim, L. L. (2021). Vasomotor symptoms in menopause: modifying the unmodifiable. BJOG: An International Journal of Obstetrics & Gynaecology, 128(3), 614-614.

11

James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., ... & Briko, A. N. (2021). Policy and technical considerations for implementing a risk-based approach to international travel in the context of COVID-19. The Lancet, 392(10159), 1789-1858.

12

Tan, Y. J., Lim, S. Y., Yong, V. W., Choo, X. Y., Ng, Y. D., Sugumaran, K., ... & Tan, A. H. (2021). Osteoporosis in Parkinson's Disease: Relevance of Distal Radius Dual-Energy X-Ray Absorptiometry (DXA) and Sarcopenia. Journal of Clinical Densitometry, 24(3), 351-361.
No. Publications

1

Lai, L. L., Vethakkan, S. R., Mustapha, N. R. N., Mahadeva, S., & Chan, W. K. (2020). Empagliflozin for the treatment of nonalcoholic steatohepatitis in patients with type 2 diabetes mellitus. Digestive Diseases and Sciences, 65(2), 623-631.

2

Chuah, K. H., Lai, L. L., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., & Chan, W. K. (2020). Liver stiffness measurement in non‐alcoholic fatty liver disease: two is better than one. Journal of Gastroenterology and Hepatology.

3

Loganathan, R., Tarmizi, A. H. A., Vethakkan, S. R., & Teng, K. T. (2020). Retention of Carotenes and Vitamin E, and Physico-chemical Changes Occurring upon Heating Red Palm Olein Using Deep-fat Fryer, Microwave Oven and Conventional Oven. Journal of Oleo Science, 69(3), 167-183.

4

Tan, E. Z., Lai, L. L., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., & Chan, W. K. (2020). Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus. Journal of gastroenterology and hepatology, 10.1111/jgh.15160. Advance online publication.

5

Loganadan, N. K., Huri, H. Z., Vethakkan, S. R., & Hussein, Z. (2020). Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study. Pharmacogenomics, 21(9), 587–600.

6

Loganadan, N. K., Huri, H. Z., Vethakkan, S. R., & Hussein, Z. (2020). Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study. Pharmacogenomics, 21(9), 587–600.

7

Loganathan, R., Tarmizi, A. H. A., Vethakkan, S. R., & Teng, K. T. (2020). Storage Stability Assessment of Red Palm Olein in Comparison to Palm Olein. Journal of Oleo Science, 69(10), 1163-1179.

8

Samsuddin S, Arumugam PA, Md. Amin MS, Yahya A, Musa N, Lim LL, Paramasivam SS, Ratnasingam J, Ibrahim L, Chooi KC, Tan AT. Maternal lipids are associated with newborn adiposity, independent of GDM status, obesity and insulin resistance: a prospective observational cohort study. BJOG: An International Journal of Obstetrics & Gynaecology. 2020 Mar;127(4):490-9.

9

Tan, H. T., Tan, C. Y., Teong, C. S., Ratnasingam, J., & Goh, K. J. (2020). Prolonged Exercise Test in Patients With History of Thyrotoxicosis. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, 10.1097/WNP.0000000000000766. Advance online publication.

10

Rama Chandran, S., A. Vigersky, R., Thomas, A., Lim, L. L., Ratnasingam, J., Tan, A., & SL Gardner, D. (2020). Role of composite glycemic indices: a comparison of the comprehensive glucose pentagon across diabetes types and hba1c levels. Diabetes technology & therapeutics, 22(2), 103-111.

11

Zainuddin, N. M., Sthaneshwar, P., & Ratnasingam, J. (2020). Screening for phaeochromocytoma in patients with acute cerebrovascular disease: Is it necessary? Malaysian Journal of Pathology, 42(2), 203-207.

12

Hassanein, M., Al Sifri, S., Shaikh, S., Raza, S. A., Akram, J., Pranoto, A., ... & Al Awadi, F. (2020). A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN. Diabetes research and clinical practice, 163, 108154.

13

Lim, L. L., Lau, E. S., Fung, E., Lee, H. M., Ma, R. C., Tam, C. H., ... & Jenkins, A. (2020). Circulating branched‐chain amino acids and incident heart failure in type 2 diabetes: The Hong Kong Diabetes Register. Diabetes/Metabolism Research and Reviews, 36(3), e3253.

14

Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., ... & Ahmadian, E. (2020). Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 395(10225), 709-733.

15

Sepanlou, S. G., Safiri, S., Bisignano, C., Ikuta, K. S., Merat, S., Saberifiroozi, M., ... & Adedoyin, R. A. (2020). The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet gastroenterology & hepatology, 5(3), 245-266.

16

Kong, A. P., Lew, T., Lau, E. S., Lim, L. L., Kesavadev, J., Jia, W., ... & Yoon, K. H. (2020). Real‐world data reveal unmet clinical needs in insulin treatment in Asians with type 2 diabetes‐the Joint Asia Diabetes Evaluation (JADE) Register. Diabetes, Obesity and Metabolism.

17

Rama Chandran, S., A Vigersky, R., Thomas, A., Lim, L. L., Ratnasingam, J., Tan, A., & S L Gardner, D. (2020). Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels. Diabetes technology & therapeutics, 22(2), 103–111.

18

Local Burden of Disease Educational Attainment Collaborators (2020). Mapping disparities in education across low- and middle-income countries. Nature, 577(7789), 235–238.

19

Loh, H. H., Yee, A., Loh, H. S., Kanagasundram, S., Francis, B., & Lim, L. L. (2020). Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis. Hormones (Athens, Greece), 19(3), 413–423.

20

Lim, Q. H., & Lim, L. L. (2020). Vasomotor symptoms in menopause: modifying the unmodifiable. BJOG : an international journal of obstetrics and gynaecology, 10.1111/1471-0528.16428. Advance online publication. https://doi.org/10.1111/1471-0528.16428

21

Ganju, A., Goulart, A. C., Ray, A., Majumdar, A., Jeffers, B. W., Llamosa, G., Cañizares, H., Ramos-Cañizares, I. J., Fadhil, I., Subramaniam, K., Lim, L. L., El Bizri, L., Ramesh, M., Guilford, M., Ali, R., Devi, R. D., Malik, R. A., Potkar, S., & Wang, Y. P. (2020). Systemic Solutions for Addressing Non-Communicable Diseases in Low- and Middle-Income Countries. Journal of multidisciplinary healthcare, 13, 693–707.

22

Micah, A. E., Su, Y., Bachmeier, S. D., Chapin, A., Cogswell, I. E., Crosby, S. W., ... & Sahu, M. (2020). Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3. The Lancet.

23

Murray, C. J., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., ... & Abegaz, K. H. (2020). Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1223-1249.

24

Wang, H., Abbas, K. M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., ... & Abushouk, A. I. (2020). Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1160-1203.

25

Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., ... & Abdollahi, M. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204-1222.

26

Murray, C. J., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasi-Kangevari, M., Abd-Allah, F., ... & Aboyans, V. (2020). Five insights from the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1135-1159.

27

Lim, L. L., Lau, E. S., Ozaki, R., Chung, H., Fu, A. W., Chan, W., ... & Cheung, K. K. (2020). Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysis. PLoS Medicine, 17(10), e1003367.

28

Lozano, R., Fullman, N., Mumford, J. E., Knight, M., Barthelemy, C. M., Abbafati, C., ... & Abolhassani, H. (2020). Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet.

29

Tan, Y. J., Lim, S. Y., Yong, V. W., Choo, X. Y., Ng, Y. D., Sugumaran, K., ... & Grossmann, M. (2020). Osteoporosis in Parkinson's Disease: Relevance of Distal Radius Dual-Energy X-Ray Absorptiometry (DXA) and Sarcopenia. Journal of Clinical Densitometry.
No. Publications

1

ZAINUDDIN, N. M., Sthaneshwar, P., & Vethakkan, S. R. D. B. (2019). Acute Intermittent Porphyria: A rare cause of hyponatraemia. The Malaysian journal of pathology, 41(3), 369./td>

2

Samsuddin, S., Arumugam, P. A., Md. Amin, M. S., Yahya, A., Musa, N., Lim, L. L., ... & Tan, A. T. B. (2019). Maternal lipids are associated with newborn adiposity, independent of GDM status, obesity, and insulin resistance: a prospective observational cohort study. BJOG: An International Journal of Obstetrics & Gynaecology.

3

Lai, L. L., Wan Yusoff, W. N. I., Vethakkan, S. R., Nik Mustapha, N. R., Mahadeva, S., & Chan, W. K. (2019). Screening for non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography. Journal of gastroenterology and hepatology, 34(8), 1396-1403.

4

Loh, H. H., Lim, L. L., Yee, A., Loh, H. S., & Vethakkan, S. R. (2019). Effect of vitamin D replacement in primary hyperparathyroidism with concurrent vitamin D deficiency: a systematic review and meta-analysis. Minerva endocrinologica, 44(2), 221-231.

5

Chooi, K. C., Ratnasingam, J., Paramasivam, S., Ibrahim, L., Tan, A., Lim, Q., ... & Vethakkan, S. (2019). OR11-5 Early Prevalence of Neuroendocrine Dysfunction after Spontaneous Aneurysmal Subarachnoid Haemorrhage: Interim Findings from a Prospective Cohort Study. Journal of the Endocrine Society, 3(Supplement_1), OR11-5.

6

Lai, L. L., Vethakkan, S. R., Mustapha, N. R. N., Mahadeva, S., & Chan, W. K. (2019). Empagliflozin for the treatment of nonalcoholic steatohepatitis in patients with type 2 diabetes mellitus. Digestive diseases and sciences, 1-9.

7

Hussein, Z., Bidin, M. L., Alias, A., Thiagarajan, M., Latif, K. A., Ratnasingam, J., ... & Nasruddin, A. (2019). Malaysian Consensus Statement for the Diagnosis and Management of Acromegaly. Journal of the ASEAN Federation of Endocrine Societies, 34(1).

8

Rama Chandran, S., Vigersky, R. A., Thomas, A., Lim, L. L., Ratnasingam, J., Tan, A., & Gardner, D. S. (2019). Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels. Diabetes technology & therapeutics.

9

Loh, H. H., Lim, L. L., Yee, A., & Loh, H. S. (2019). Association between subclinical hypothyroidism and depression: an updated systematic review and meta-analysis. BMC psychiatry, 19(1), 12.

10

Chan, J. C., Lim, L. L., Luk, A. O., Ozaki, R., Kong, A. P., Ma, R. C., ... & Lo, S. V. (2019). From Hong Kong Diabetes Register to JADE Program to RAMP-DM for data-driven actions. Diabetes care, 42(11), 2022-2031.

11

Loh, H. H., Lim, L. L., Loh, H. S., & Yee, A. (2019). Safety of Ramadan fasting in young patients with type 1 diabetes: A systematic review and meta‐analysis. Journal of diabetes investigation, 10(6), 1490-1501.

12

Burstein, R., Henry, N. J., Collison, M. L., Marczak, L. B., Sligar, A., Watson, S., ... & Abdoli, A. (2019). Mapping 123 million neonatal, infant and child deaths between 2000 and 2017. Nature, 574(7778), 353-358.

13

Lim, L. L., & Chan, J. C. (2019). Sodium-glucose co-transporter-2 inhibitors: know the patient and the drugs.

14

Lim, L. L., Fu, A. W., Lau, E. S., Ozaki, R., Cheung, K. K., Ma, R. C., ... & Kong, A. P. (2019). Sudomotor dysfunction independently predicts incident cardiovascular–renal events and all-cause death in type 2 diabetes: the Joint Asia Diabetes Evaluation register. Nephrology Dialysis Transplantation, 34(8), 1320-1328.

15

Lim, L. L., Lau, E. S., Lee, H. M., Tam, C. H., Lim, C. K., Luk, A., ... & Kong, A. P. (2019). 533-P: Association of Serum Branched-Chain Amino Acids with Kidney Function Decline in Type 2 Diabetes: The Hong Kong Diabetes Register.

16

Liew, J., Barlow, A., Lim, L. L., Suastika, K., Yasahardja, Y., Chan, S. P., ... & Tan, A. T. (2019). 2244-PUB: Role of B Vitamins (B1, B6, B12) in Managing Diabetic Peripheral Neuropathy (DPN): A Systematic Review.

17

Chang, A. Y., Cowling, K., Micah, A. E., Chapin, A., Chen, C. S., Ikilezi, G., ... & Zhao, Y. (2019). Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050. The Lancet, 393(10187), 2233-2260.

18

Lim, L. L., Tse, G., Choi, K. C., Zhang, J., Luk, A. O., Chow, E., ... & Chan, J. C. (2019). Temporal changes in obesity and sleep habits in Hong Kong Chinese school children: a prospective study. Scientific reports, 9(1), 1-7.

19

Lim, L. L., Lee, H. M., Lau, E., Luk, A., Chow, E., Ma, R., ... & Kong, A. (2019). SAT-134 Association between Serum Branched-Chain Amino Acids and Cancer Risk: The Hong Kong Diabetes Register (HKDR). Journal of the Endocrine Society, 3(Supplement_1), SAT-134.

Last Update: 06/11/2024